Navigation Links
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Date:12/17/2009

pment experience, having held leadership roles at Pfizer in clinical and development programs that resulted in the approval of three marketed drugs, Geodon oral, Geodon IM and Chantix. Under Karen's leadership as global clinical leader and development team leader, Chantix received priority review from the FDA and was granted the Prix Galien USA Award in 2007, an award considered by many to be the highest accolade in pharmaceutical research and development."

Dr. Reeves received her B.A. from Yale University and M.D. from the University of Vermont Medical School.

Mr. Selby joined Medivation in October 2007 as a senior director of biometrics, bringing 20 years experience in analyzing clinical trial data in oncology, vascular disease, infectious disease, pain management and auto-immune disease indications. Prior to joining Medivation, he served as a director of statistical programming at ALZA/Johnson & Johnson, Nuvelo, Inc., Corgentech Inc. and InterMune, Inc., and he has performed various statistician and statistical programming functions for companies including Abgenix, Inc., Gilead Sciences, Genentech, Inc., Matrix Pharmaceutical and Monsanto. Mr. Selby earned his B.A. in mathematics from Washburn University and his M.S. in statistics from Kansas State University.

Ms. Date joined Medivation in April 2007 as senior director of intellectual property, bringing 14 years of intellectual property related experience and over five years of experience as a research chemist. Prior to joining Medivation, she served as a director of intellectual property at Threshold Pharmaceuticals, Inc. and a patent attorney at ALZA/Johnson & Johnson and held various patent-related positions at Robins & Associates and Glycomed Inc. Ms. Date received her M.S. in chemistry from both Bombay University and Duke University and a J.D. from Golden Gate University School of Law.

*Latrepirdine is the proposed generic (nonproprietary) name for d
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
2. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
3. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
4. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
5. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
6. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
7. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
8. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
9. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
10. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
11. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- Quantum Materials Corporation (OTCQB:QTMM) (QMC) announced today the addition of Mr. ... the Board of Directors. QMC also announced formation of a Scientific ... Science Officer and Board of Directors Member, along with Scientific Advisory ... Mr. Tomio Gotoh , a pioneer of the Personal Computer ... Materials welcomes two new outside Board members, Mr. Ray ...
(Date:7/21/2014)... LOS ANGELES , July 21, 2014 /PRNewswire-iReach/ -- ... nitric oxide supplements , will celebrate its first anniversary ... supplement that is designed to enhance the body,s ability ... original formula that is made up of a variety ... spokesperson said have been found to increase nitric ...
(Date:7/21/2014)... , July 21, 2014  EHE International, the recognized ... a nationwide physician network, today announced that Dignity Health ... NV has been named an EHE-certified preventive ... Las Vegas region now have greater ... maintain their health. "EHE is proud ...
Breaking Medicine Technology:Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2
... PRNewswire / -- Cadence Pharmaceuticals, Inc. (NASDAQ: ... developing and commercializing proprietary products principally for use in ... and CEO Ted Schroeder will present the company,s corporate ... Time (10:30am Pacific Time) during the Jefferies 2011 Global ...
... N.J., June 2, 2011 Soligenix, Inc. ... company, announced today that it recently appointed Joseph Warusz ... In this role, Mr. Warusz will oversee the Accounting, ... as the Company,s Principal Accounting Officer for SEC reporting ...
Cached Medicine Technology:Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller 2Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller 3Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller 4
(Date:7/22/2014)... (PRWEB) July 22, 2014 Legislation ... Seniors Access to Local Pharmacies Act of 2014”) ... Part D would undermine the availability of lower ... by $21 billion over the next 10 years, ... released by the Pharmaceutical Care Management Association (PCMA). ...
(Date:7/22/2014)... Autoimmune disorders may share certain pathogenic mechanisms with cancer, ... (GW) researcher Linda Kusner, Ph.D. , published in ... paradigm shifting work shows that the very same inhibitors ... expressed in cells that produce autoimmune diseases. Henry ... at the GW School of Medicine and Health Sciences ...
(Date:7/22/2014)... The Beryl Institute announces its fifth annual Patient ... These offerings reinforce the Institute’s commitment to support the ... the need for rigorous research to understand and address ... are intended to encourage and support research into ... the patient experience before, during and after care (e.g., ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... the way in providing resources, educational tools and recognition ... tell the stories of prevention, treatment and recovery. On ... BLACK BOX will spotlight some of these resources with ... Health Services Administration helpline and treatment website at the ...
(Date:7/22/2014)... 22, 2014 (HealthDay News) -- One of the largest ... psychiatric disorder has uncovered 83 new sites on chromosomes ... findings, made by an international team of researchers, now ... to the disorder to 108. Although these ... a test to predict who will or will not ...
Breaking Medicine News(10 mins):Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:New research finds pathogenic connection between autoimmune disorders and cancer 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2
... older adults, already shown to improve health, can also cut ... the University of Washington. The study appears in the February ... depression affects about 3 million older adults in the United ... health-care expenses, mostly due to an increased use of medical, ...
... Regional,Foodbank, which distributes millions of pounds of food to ... more than 30,000 pounds of meat,to help feed local ... America tour, an initiative led by celebrity cook,Paula Deen., ... servings of meat to the,nation,s hungry families, including those ...
... Feb. 6 Worrell Inc., a full-service,product design ... the Montreal and San Diego offices of Gad ... prowess with the,engineering proficiencies of Gad Shaanan Design., ... Worrell Inc.,-- International Kai Worrell. "We know how ...
... Presented at 15th Conference on ... Opportunistic Infections (CROI), BOSTON, Feb. 6 Schering-Plough ... of a Phase II clinical study,showed vicriviroc, its investigational ... weeks of therapy in treatment-,experienced HIV-infected patients, when administered ...
... (February 6, 2008)Perhaps the only positive spin one can put ... Other than that, the news is bad. It is nearly ... of their lives, and the limited treatment options have changed ... are determined to find new ways treat this poorly understood ...
... for Health Solutions study outlines plan to help,primary ... WASHINGTON, Feb. 6 Primary care physicians,should ... diseases,and be compensated accordingly for their enhanced role ... Deloitte Center for Health Solutions,( http://www.deloitte.com/centerforhealthsolutions ) concludes., ...
Cached Medicine News:Health News:Team treatment for depression cuts medical costs 2Health News:Team treatment for depression cuts medical costs 3Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour to L.A. 2Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour to L.A. 3Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 2Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 3Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 4Health News:Gene plays 'Jekyll and Hyde' in brain cancer 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 3Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 2Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 3
... The Infinity Creatinine single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Creatinine reagent provides a long ...
... The Infinity AST (GOT) powder reagent once ... of single liquid stability to help maximize ... quick result turnaround time. The patented technology ... provides a long shelf life and stability ...
... Re-insulation capabilities that extend the life ... that bring them back to life, expertise ... Instrument trademark. Our maintenance capabilities always help ... , Economical and fast, not only do ...
Inquire...
Medicine Products: